Javascript not supporting your browser
Clinical Monitoring
Welcome to Clinical Monitoring, the team that provides monitoring services for DMID. Sponsors of clinical investigations involving new drugs (including biological products for human use) and medical devices under 21 CFR Parts 312, and 812, are required by federal regulations to monitor the progress of the clinical investigation.
  
  
There are no items to show in this view of the "ClinicalMonitoring" document library.